Erste Asset Management GmbH Makes New Investment in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Erste Asset Management GmbH purchased a new position in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) during the third quarter, HoldingsChannel reports. The firm purchased 34,000 shares of the biotechnology company’s stock, valued at approximately $327,000. Other institutional investors have also recently bought and sold shares of the company. ORG Partners LLC acquired […]

Leave a Reply

Your email address will not be published.

Previous post Investment giant issues AI warning
Next post Donaldson (NYSE:DCI) Price Target Raised to $68.00 at Morgan Stanley